Published on 7 Sep 2022 on Seeking Alpha
GKOS stock gains as pivotal trials for eye implant reach main goals (NYSE:GKOS)
Glaukos Corporation (GKOS), a MedTech company focused on eye diseases, announced Wednesday that two...
NYSE.GKOS price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free